| Meleah R Jensen Schneider, PA-C | |
|
421 E Merle Hibbs Blvd, Mcfarland Clinic. Pc, Marshalltown, IA 50158-1992 | |
| (641) 752-5469 | |
| (641) 844-2205 |
| Full Name | Meleah R Jensen Schneider |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 19 Years |
| Location | 421 E Merle Hibbs Blvd, Marshalltown, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205864576 | NPI | - | NPPES |
| P01091014 | Other | IA | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 001648 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unitypoint Health-marshalltown | Marshalltown, IA | Hospital |
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcfarland Clinic Pc | 1254244239 | 320 |
News Archive
Non-Hispanic Black individuals in four U.S. states experienced a 38% increase in the rate of opioid overdose deaths from 2018 to 2019, while the rates for other race and ethnicity groups held steady or decreased, according to a new study by the National Institutes of Health published in the American Journal of Public Health.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
Among patients with diabetic kidney disease and hyperkalemia (elevated potassium levels in the blood), a potentially life-threatening condition, those who received the new drug patiromer, twice daily for four weeks, had significant decreases in potassium levels which lasted through one year, according to a study in the July 14 issue of JAMA.
For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meleah R Jensen Schneider, PA-C 1215 Duff Ave, Ames, IA 50010-5400 Ph: (515) 239-4400 | Meleah R Jensen Schneider, PA-C 421 E Merle Hibbs Blvd, Mcfarland Clinic. Pc, Marshalltown, IA 50158-1992 Ph: (641) 752-5469 |
News Archive
Non-Hispanic Black individuals in four U.S. states experienced a 38% increase in the rate of opioid overdose deaths from 2018 to 2019, while the rates for other race and ethnicity groups held steady or decreased, according to a new study by the National Institutes of Health published in the American Journal of Public Health.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
Among patients with diabetic kidney disease and hyperkalemia (elevated potassium levels in the blood), a potentially life-threatening condition, those who received the new drug patiromer, twice daily for four weeks, had significant decreases in potassium levels which lasted through one year, according to a study in the July 14 issue of JAMA.
For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor.
› Verified 9 days ago
Jaime M. Hooley, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 405 E Main St, Marshalltown, IA 50158 Phone: 641-753-2752 Fax: 641-753-6450 | |
Michael Eugene Knutsen, MPAS, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 421 E Merle Hibbs Blvd, Marshalltown, IA 50158 Phone: 641-844-2213 Fax: 641-752-5132 | |
Mrs. Karisa Marie Goering, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 412 E Church St, Marshalltown, IA 50158 Phone: 641-753-4021 Fax: 641-753-4025 | |
Dianne Rinehart, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 407 E Main St, Marshalltown, IA 50158 Phone: 641-752-4681 Fax: 641-752-6572 | |
Christine Anne Taylor, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 412 E Church St, Marshalltown, IA 50158 Phone: 641-753-4021 Fax: 641-753-4025 | |
Ms. Leanne K. Knoop, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 303 Nicholas Dr, Marshalltown, IA 50158 Phone: 641-752-0099 Fax: 641-752-8736 |